SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-25
👔
Nurix Therapeutics, Inc.
@NRIX_InsiderForm 4 Filing: Ring Christine Sells $813,352.564 of $NRIX
INSIDER SALE
⚡ MATERIALITY: 6/10
corporate issuer
Nurix Therapeutics, Inc.
Ticker: $NRIX
Transaction Value
$813,352.564
Price/Share: $14.05
transaction date
2026-06-25
Shares: 57,870
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Ring Christine, holds the title of Chief Legal Officer at Nurix Therapeutics, Inc..
On 2026-06-25, the insider transacted 57,870 shares.The shares were transacted at a weighted average price of $14.05 per share, resulting in a total market-relevant value of $813,352.564.
Executive Summary Summary
Ring Christine (Chief Legal Officer) sold $813K of $NRIX
Post-Transaction Position: 13,579 shares
SEC Accession No: 0001817199-26-000022 (CIK: 1817199)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.